Literature DB >> 1706320

Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.

S K Petersen1, N T Foged, A Bording, J P Nielsen, H K Riemann, P L Frandsen.   

Abstract

Potential vaccine components for protection against atrophic rhinitis in pigs were developed. This was achieved by deletion mutagenesis of the gene encoding the Pasteurella multocida toxin. Four purified toxin derivatives lacking different and widely separated regions in the amino acid sequence were characterized by a lack of toxic activity. One such component was shown to induce efficient protection of vaccinated female mice and their offspring against challenge with purified P. multocida toxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706320      PMCID: PMC257854          DOI: 10.1128/iai.59.4.1387-1393.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  The complete nucleotide sequence of the Pasteurella multocida toxin gene and evidence for a transcriptional repressor, TxaR.

Authors:  S K Petersen
Journal:  Mol Microbiol       Date:  1990-05       Impact factor: 3.501

2.  Pasteurella multocida toxin: potent mitogen for cultured fibroblasts.

Authors:  E Rozengurt; T Higgins; N Chanter; A J Lax; J M Staddon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Sequence of the dermonecrotic toxin of Pasteurella multocida ssp. multocida.

Authors:  W E Buys; H E Smith; A M Kamps; E M Kamp; M A Smits
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

4.  Partial purification of an osteolytic toxin from Pasteurella multocida.

Authors:  N Chanter; J M Rutter; A Mackenzie
Journal:  J Gen Microbiol       Date:  1986-04

5.  A toxin from Pasteurella multocida type D causes acute hepatic necrosis in pigs.

Authors:  N F Cheville; R B Rimler; J R Thurston
Journal:  Vet Pathol       Date:  1988-11       Impact factor: 2.221

6.  Pathogenesis of atrophic rhinitis in pigs: a new perspective.

Authors:  J M Rutter; A Mackenzie
Journal:  Vet Rec       Date:  1984-01-28       Impact factor: 2.695

7.  Intracellular locations of dermonecrotic toxins in Pasteurella multocida and in Bordetella bronchiseptica.

Authors:  T Nakai; A Sawata; K Kume
Journal:  Am J Vet Res       Date:  1985-04       Impact factor: 1.156

8.  Cloning of the toxin gene from Pasteurella multocida and its role in atrophic rhinitis.

Authors:  A J Lax; N Chanter
Journal:  J Gen Microbiol       Date:  1990-01

9.  Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli.

Authors:  S K Petersen; N T Foged
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

10.  Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies.

Authors:  N T Foged; J P Nielsen; S E Jorsal
Journal:  Vet Rec       Date:  1989-07-01       Impact factor: 2.695

View more
  10 in total

1.  Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus.

Authors:  B A Wilson; V G Ponferrada; J E Vallance; M Ho
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.

Authors:  J D Boyce; B Adler
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  The outer membrane of Pasteurella multocida 3:A protects rabbits against homologous challenge.

Authors:  Y S Lu; W C Lai; S P Pakes; C Stefanu
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs.

Authors:  A Bording; K Nymark; E Smidt
Journal:  Acta Vet Scand       Date:  1994       Impact factor: 1.695

6.  Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.

Authors:  Jeongmin Lee; Hae-Eun Kang; Hee-Jong Woo
Journal:  Clin Vaccine Immunol       Date:  2012-07-25

7.  Application of intact cell-based NFAT-beta-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway.

Authors:  Shuhong Luo; Mengfei Ho; Brenda A Wilson
Journal:  Toxicon       Date:  2007-11-23       Impact factor: 3.033

8.  Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxin and potassium thiocyanate extract.

Authors:  L Z Jarvinen; H Hogenesch; M A Suckow; T L Bowersock
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  Differentiation of toxigenic from nontoxigenic isolates of Pasteurella multocida by PCR.

Authors:  S Nagai; S Someno; T Yagihashi
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 11.677

Review 10.  Veterinary vaccine development from an industrial perspective.

Authors:  J G M Heldens; J R Patel; N Chanter; G J Ten Thij; M Gravendijck; V E J C Schijns; A Langen; Th P M Schetters
Journal:  Vet J       Date:  2008-03-03       Impact factor: 2.688

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.